Literature DB >> 716878

Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides.

E Azizi, J L Zaidman, J Eshchar, A Szeinberg.   

Abstract

An 11-year-old girl with abetalipoproteinemia was treated with parenteral vitamin A and vitamin E for two and a half years. Some improvement in neurological and visual deficits was noted. On changing to oral vitamin E and later with addition of medium chain triglycerides (MCT) to the diet, a considerable improvement in her general wellbeing, neuromuscular lesions and ophthalmological symptoms was noted. This regimen is being adhered to for five and a half years. The condition is stable with no further improvement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 716878     DOI: 10.1111/j.1651-2227.1978.tb16264.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  14 in total

1.  Abetalipoproteinemia in an Indian family.

Authors:  M V Padma; S Jain; M C Maheshwari
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

2.  Physiological and therapeutic role of vitamin E in humans: an update.

Authors:  K D Moudgil; B S Narang
Journal:  Indian J Pediatr       Date:  1984 Nov-Dec       Impact factor: 1.967

3.  Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy.

Authors:  R A Hegele; A Angel
Journal:  Can Med Assoc J       Date:  1985-01-01       Impact factor: 8.262

4.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 5.  Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

Authors:  Noel Peretti; Agnès Sassolas; Claude C Roy; Colette Deslandres; Mathilde Charcosset; Justine Castagnetti; Laurence Pugnet-Chardon; Philippe Moulin; Sylvie Labarge; Lise Bouthillier; Alain Lachaux; Emile Levy
Journal:  Orphanet J Rare Dis       Date:  2010-09-29       Impact factor: 4.123

6.  Neuropathology of chronic vitamine E deficiency in fatal familial intrahepatic cholestasis.

Authors:  K Saito; T Yokoyama; M Okaniwa; S Kamoshita
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

7.  Abetalipoproteinaemia in adults: role of vitamin therapy.

Authors:  A J MacGilchrist; P R Mills; M Noble; W S Foulds; J A Simpson; G Watkinson
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

8.  Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.

Authors:  S Bishara; S Merin; M Cooper; E Azizi; G Delpre; R J Deckelbaum
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

9.  Histochemical and ultrastructural pathology of skeletal muscle in a patient with abetalipoproteinemia.

Authors:  I Higuchi; T Yamano; M Kuriyama; K Niina; M Nakase; M Umemoto; H Take; M Osame
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia.

Authors:  P Runge; D P Muller; J McAllister; D Calver; J K Lloyd; D Taylor
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.